Racial differences in the use of drug therapy for HIV disease

Paul A. Simon, Frank J. Sorvillo, Richard K. Lapin, Richard D. Moore, Richard E. Chaisson

Research output: Contribution to journalLetterpeer-review

Abstract

To the Editor: Moore et al. (March 17 issue)1 present data suggesting that among patients seeking treatment at their Baltimore HIV clinic, blacks were less likely than whites to have received previous antiretroviral therapy or prophylaxis against Pneumocystis carinii pneumonia (PCP). Although data were obtained from patients' reports and “accompanying medical records when available,” Moore and colleagues do not report the degree to which data from patients' reports were validated by reviews of medical records. As part of an ongoing interview project sponsored by the Centers for Disease Control and Prevention,2 we have collected similar data on medical care in.

Original languageEnglish (US)
Pages (from-to)333-334
Number of pages2
JournalNew England Journal of Medicine
Volume331
Issue number5
DOIs
StatePublished - Aug 4 1994

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Racial differences in the use of drug therapy for HIV disease'. Together they form a unique fingerprint.

Cite this